Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
mass-spectrometry
Press Release
May 23, 2023
Photonis Expands Market-Leading Mass Spectrometry Detection Technology
Visit Photonis at booth #407 during the 71st ASMS Conference
Read More
Press Release
Oct 29, 2021
Photonis Scientific Demonstrates Its Market-Leading MS Detection Technology at the 69th ASMS Conference on Mass Spectrometry and Allied Topics
Read More
Press Release
Apr 2, 2021
Hardy Diagnostics Releases New Mass Spectrometer for Use in Non-Clinical Applications
Read More
Press Release
Feb 11, 2020
Molecular Diagnostics Market to Hit US $15B by 2026: Global Market Insights, Inc.
Germany molecular diagnostics market demand is estimated to witness around a 7.5% CAGR from 2020 to 2026, owing to changing lifestyle preferences, rising incidences of infectious diseases and favorable demographic trends, such as a graying population.
Read More
Press Release
Apr 11, 2018
Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks
Support of discovery programs is essential to providing integrated drug development services. The key is to have the expertise to be able to tackle complex matrices along with any biomarker component.
Read More
Press Release
Feb 27, 2018
Immunoprecipitation of Disease-Associated Proteins for Alzheimers' Research, New Webinar Hosted by Xtalks
Immunoprecipitation in combination with mass spectrometry is a powerful tool for studying disease-associated proteins
Read More
Press Release
May 31, 2017
Global Metabolomics Market to Be Worth $2,455.4 Million by 2023
Factors such as government funding, introduction of computer-based metabolomics, and wide range of metabolomics application in R&D and therapeutic areas are expected to drive the market growth during the forecast period
Read More
Press Release
Sep 1, 2016
Novel Test Distinguishes Atypical Moles From Melanoma
For centuries pathologists have relied on the microscopic examination of tumors to distinguish between atypical moles and melanoma. By analyzing the level of proteins within mole cells, mass spectrometry can aid in the diagnosis of atypical moles. In this study, mass spectrometry correlated better than the gold standard of histologic examination to determine if an atypical mole was in fact benign or a melanoma. Early diagnosis of melanoma is critical to cure and long term survival.
Read More
Press Release
May 19, 2010
Ocimum launches massspectrometry services
Ocimum Biosolutions has launched its mass spectrometry services using MALDI-TOF system in India
Read More
First
Prev
1
Next
Last